Comparison of epoetin alfa and darbepoetin alfa biological activity under different administration schedules in normal mice

被引:14
|
作者
Sasu, BJ [1 ]
Hartley, C [1 ]
Schultz, H [1 ]
McElroy, P [1 ]
Khaja, R [1 ]
Elliott, S [1 ]
Egrie, JC [1 ]
Browne, JK [1 ]
Begley, CG [1 ]
Molineux, G [1 ]
机构
[1] Amgen Inc, Dept Hematol, Thousand Oaks, CA 91320 USA
关键词
Aranesp (R); darbepoetin alfa; epoetin alfa; erythropoietic units; hemoglobin;
D O I
10.1159/000084446
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The unit of erythropoietic activity has long been the standard by which erythropoietic agents are judged, but the development of long-acting agents such as darbepoetin alfa has highlighted the shortcomings of this approach. To this point, we compared the in vivo activity of Epoetin alfa and darbepoetin alfa per microgram of protein core. Using the established mass-to-unit conversion for Epoetin alfa (1 mu g congruent to 200 U), we then calculated darbepoetin alfa activity in units. Activity varied with treatment regimen (1 mu g darbepoetin alfa congruent to 800 U for 3 times weekly dosing to 8,000 U for a single injection). This analysis reveals the inadequacy of evaluating darbepoetin alfa activity in terms of standard erythropoietic units. We therefore propose that for molecules with heightened biological activity, a more legitimate basis for comparison is the protein mass. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:163 / 174
页数:12
相关论文
共 50 条
  • [1] Clinical and economic comparison of epoetin alfa and darbepoetin alfa
    Morreale, A
    Plowman, B
    DeLattre, M
    Boggie, D
    Schaefer, M
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (03) : 381 - 395
  • [2] Comments on clinical and economic comparison of epoetin alfa and darbepoetin alfa
    Sullivan, SD
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (09) : 1461 - 1461
  • [3] Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness
    Voils, Stacy A.
    Harpe, Spencer H.
    Brophy, Gretchen M.
    PHARMACOTHERAPY, 2007, 27 (04): : 535 - 541
  • [4] Cross lineage effects of darbepoetin alfa in normal mice: A comparison with recombinant human erythropoietin, darbepoetin alfa and pegylated-darbepoetin alfa
    Briddell, R
    Argento, J
    Del Castillo, J
    Hartley, C
    Khaja, R
    Khonsari, K
    Hill, D
    Ring, B
    Sarosi, I
    Begley, G
    Molineux, G
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (07) : 164 - 165
  • [5] Comparison of epoetin alfa and darbepoetin alfa treatment costs in an inpatient oncology setting
    Duh, M
    Vekeman, F
    McKenzie, RS
    Lefebvre, P
    Watson, S
    Mody, S
    Piech, CT
    VALUE IN HEALTH, 2006, 9 (03) : A19 - A19
  • [6] Cross lineage effects of darbepoetin alfa in normal mice: A comparison with recombinant human erythropoietin, darbepoetin alfa and pegylated-darbepoetin alfa.
    Briddell, R
    Argento, J
    del Castillo, J
    Hill, D
    Hartley, C
    Khaja, R
    Khonsari, K
    Ring, B
    Sarosi, I
    Begley, G
    Molineux, G
    BLOOD, 2003, 102 (11) : 163B - 164B
  • [7] The Impact of Methodological Approach on Cost Findings in Comparison of Epoetin Alfa with Darbepoetin Alfa
    Song, Xue
    Long, Stacey R.
    Marder, William D.
    Sullivan, Sean D.
    Kallich, Joel
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (7-8) : 1203 - 1210
  • [8] Comparison of doses of epoetin alfa and darbepoetin alfa required for maintenance of haemoglobin levels
    Pussell, BA
    Walker, R
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V258 - V259
  • [9] Comparison of effects of darbepoetin alfa and epoetin alfa on serum endothelin level and blood pressure
    Mehmet Kanbay
    Ali Akcay
    Tuncay Delibasi
    Burak Uz
    Arif Kaya
    Cemile Koca
    Faruk Turgut
    Nuket Bavbek
    Ebru Uz
    Murat Duranay
    Ramazan Yigitoglu
    Advances in Therapy, 2007, 24 : 346 - 352
  • [10] Comments and response on clinical and economic comparison of epoetin alfa and darbepoetin alfa - Authors reply
    Morreale, AP
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (09) : 1462 - 1463